Product Information
- 1-(4-(5-(4-Chlorophenyl)-4-(pyrimidin-4-yl)-1H-pyrazol-3-yl)piperidin-1-yl)-2-hydroxyethanone3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4- (4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole
SD 0006 is an anti-inflammatory agent that inhibits the p38mapk enzyme and prevents the activation of voltage-dependent calcium channels. It has been shown to inhibit light emission in bacterial cells, which may be due to its ability to block calcium channels. SD 0006 also has a protective effect on ischemia reperfusion injury in a rat model. The drug binds to the ryanodine receptor and inhibits receptor binding, preventing the release of calcium from intracellular stores. SD 0006 may be used for the treatment of metabolic disorders such as type 2 diabetes and inflammatory diseases such as psoriasis or rheumatoid arthritis.
Chemical properties
Technical inquiry about: 3D-FC145174 SD 0006
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
